Theriva Biologics, Inc.
TOVXDrugs in Pipeline
4
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
Get an email about TOVX's next catalysts
Track Theriva Biologics (TOVX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
2 upcoming, 0 past
TOVX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
VCN-01 oncolytic adenovirus (zabilugene almadenorepvec) Phase 2 Est. Readout (VIRAGE2)
Estimated primary completion for VCN-01 oncolytic adenovirus (zabilugene almadenorepvec) trial (NCT07701486) in Pancreas Cancer, Metastatic. Topline data typically follows completion by weeks to months.
SourceVCN-01 oncolytic adenovirus (zabilugene almadenorepvec)
Pancreas Cancer, Metastatic
Period 1 - Treatment Sequence AB
Healthy Volunteers
SYN-004
Healthy Volunteers With Ileostomy
SYN-010
Irritable Bowel Syndrome With Constipation (IBS-C)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VCN-01 oncolytic adenovirus (zabilugene almadenorepvec) | Phase 2 | Pancreas Cancer, Metastatic | - | - |
Period 1 - Treatment Sequence AB | Phase 2 | Healthy Volunteers | - | - |
SYN-004 | Phase 2 | Healthy Volunteers With Ileostomy | - | - |
SYN-010 | Phase 2 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Theriva Biologics, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Theriva Biologics, Inc.'s (TOVX) pipeline across Phase 2. Its lead program is VCN-01 oncolytic adenovirus (zabilugene almadenorepvec) (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Theriva Biologics, Inc.'s next FDA catalyst?→
Theriva Biologics, Inc.'s (TOVX) next tracked catalyst is a Phase 2 readout expected August 1, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TOVX biotech catalysts?→
Add TOVX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Theriva Biologics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.